The Australian Early Psychosis Collaborative Consortium (AEPCC) is establishing a Clinical Trials and Translation Network (CTTN), a Clinical Quality Registry (CQR) and a Lived Experience Network (LEN).
Through these three programs, we’re bringing together the national early psychosis community like never before – to work collaboratively and effectively to improve outcomes for young people experiencing early psychosis.
As a clinical trials network, the AEPCC CTTN will be an enabling platform to facilitate early psychosis research across Australia, the first of its kind in youth mental health and early psychosis. We have added an additional element – translation – to ensure research findings are translated into clinical practice.
While the AEPCC CTTN is the only mental health clinical trials network focused exclusively on young people with early psychosis, two clinical trials networks in the mental health sector are also being established: MAGNET and Growing Minds Australia.
How does it work?
The AEPCC CTTN is a facilitating clinical trials network, building a national network driving innovation to ensure young people experiencing early psychosis receive the best treatment when they most need it, giving them the very best opportunity to live a full and well life.
The network will bring together researchers, clinicians and the lived experience community to:
- set priority areas for early psychosis research;
- facilitate collaborative multi-site early psychosis research trials; and
- provide a framework for streamlining the translation of research into real-world practice.
AEPCC won’t have a direct role in trial management or coordination and will not act as a research trial sponsor.
Why take part?
Through the CTTN, AEPCC will support early psychosis research by:
- providing review and endorsement of multi-site early psychosis clinical trials
- providing expert advice and feedback on trial design and feasibility;
- facilitating introductions to potential trial recruitment sites and research collaborators;
- facilitating grant development in key priority areas identified by the AEPCC community including but not limited to grant writing, biostatistical review and support, implementation science and knowledge translation expertise;
- hosting AEPCC research forums and workshops; and
- providing research-focussed training across the early psychosis community.
Click below to find more information and resources about the benefits of establishing a clinical trials network.
Get involved
AEPCC membership
Apply for free AEPCC membership to be involved, connected and supported.
AEPCC CTTN support request
If you’re part of the early psychosis research and/or clinical community, please get in touch.